Oral Sleep Apnea Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, Sales Channel, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Oral Sleep Apnea Devices Market size was more than USD 1.07 billion in 2026 and is set to grow at a 5.43% CAGR between 2027 and 2036, surpassing USD 1.82 billion by 2036. The industry revenue for 2027 is assessed at USD 1.12 billion.
Get more details on this report
Request Free Sample ReportOral Sleep Apnea Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to established treatment pathways, stronger provider networks, and wider acceptance of customized oral appliance therapy.
- Asia Pacific is projected to grow at a 7.8% CAGR, supported by improving diagnosis rates and expanding dental and sleep care access.
Segment Momentum
- Mandibular Advancement Devices lead the market due to strong clinical familiarity, routine use in dental sleep medicine, and broad patient acceptance for managing mild to moderate obstructive sleep apnea and snoring.
- Online Sales is the fastest-growing channel as consumers increasingly research sleep solutions independently and prefer convenient purchasing options with easier product access and transaction completion.
Market Expansion Drivers
- Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies.
- Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance.
- Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption.
Leading Market Participants
- Leading companies in the oral sleep apnea devices market include ResMed Inc. (United States), SomnoMed Limited (Australia), ProSomnus Sleep Technologies, Inc. (United States), Vivos Therapeutics, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Oventus Medical Ltd. (Australia), Airway Management Inc. (United States), Whole You, Inc. (United States), Apnea Sciences Corporation (United States), DynaFlex (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.07 billion
- 2027 Estimated Market Size: USD 1.12 billion.
- Projected Market Size: USD 1.82 billion by 2036
- Growth Forecast: 5.43% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Mandibular Advancement Devices (Product) | Direct Sales (Sales Channel) | Homecare Settings (End-use)
- Emerging Opportunity Segment: Tongue Retaining Devices (Product) | Online Sales (Sales Channel) | Homecare Settings (End-use)
Market Growth Drivers and Industry Trends
Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies
Growing prevalence of obstructive sleep apnea is increasing the need for effective treatment options that can address airway obstruction without relying exclusively on invasive approaches, thereby supporting oral sleep apnea devices market growth. Oral appliances can help reposition the jaw or tongue to maintain airway openness during sleep, providing an alternative for patients who require non-invasive management. Greater awareness of sleep-related breathing disorders and the health consequences associated with untreated sleep apnea is also encouraging more individuals to seek diagnosis and treatment.
Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance
Patient preference for more comfortable and convenient treatment options is encouraging greater consideration of mandibular advancement appliances, which will propel oral sleep apnea devices market growth. Some patients may experience discomfort, inconvenience, or difficulty maintaining consistent use of PAP-based therapies, creating interest in oral devices that are compact and easier to incorporate into nighttime routines. Mandibular advancement appliances are designed to adjust jaw positioning during sleep, providing a less cumbersome treatment format for suitable patients and supporting continued adherence to prescribed therapy.
Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption
The expansion of telehealth is making sleep disorder consultations and diagnostic pathways more accessible, creating favorable conditions for oral sleep apnea devices market growth. Remote consultations can help patients initiate discussions about symptoms, undergo preliminary assessments, and access follow-up care without requiring frequent in-person visits. As digital healthcare services become more integrated with sleep disorder management, patients may also find it easier to explore and obtain suitable oral appliance solutions through increasingly accessible care and purchasing pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance | 1.80% | Moderate | North America, Asia Pacific | High | Near Term |
| Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption | 1.30% | Low | Asia Pacific, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The oral sleep apnea devices market was led by North America in 2026, reflecting high awareness of sleep-disordered breathing, established diagnostic pathways, and growing acceptance of non-invasive treatment alternatives. Dental and sleep medicine professionals increasingly recognize oral appliances as a practical option for eligible patients seeking alternatives to conventional therapies. Improvements in device design, expanding professional education, and greater attention to untreated sleep apnea are supporting adoption across specialized healthcare settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region as awareness of sleep-related disorders improves and access to specialized dental and sleep healthcare expands. Rising urbanization, changing lifestyles, and increasing recognition of the health consequences associated with untreated sleep apnea are encouraging more patients to seek diagnosis and treatment. Development of specialized clinics, improving healthcare infrastructure, and growing acceptance of minimally invasive treatment options are further supporting the adoption of oral sleep apnea devices.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Dental CollaborationGermany promotes close collaboration between dental specialists and sleep physicians to improve oral appliance therapy outcomes. Providers in Germany increasingly adopt digitally designed devices that enhance treatment precision while supporting long-term patient adherence.
France 🇫🇷
Integrated Sleep CareFrance supports oral sleep apnea devices through coordinated treatment pathways involving sleep clinics and dental practitioners. Healthcare providers in France continue encouraging personalized oral appliance therapy for suitable patients seeking non-invasive treatment options.
Italy 🇮🇹
Specialist Dental SolutionsItaly focuses on expanding specialist dental services that deliver tailored oral sleep apnea devices for long-term therapy. Dental professionals in Italy increasingly prioritize precise appliance adjustment and patient follow-up to improve treatment effectiveness and compliance.
Japan 🇯🇵
Compact Patient ComfortJapan emphasizes compact, comfortable oral sleep apnea devices designed to improve treatment acceptance among patients. Dental professionals in Japan continue integrating digital impressions and precision manufacturing to deliver well-fitted appliances for obstructive sleep apnea management.
South Korea 🇰🇷
Digital Appliance ManufacturingSouth Korea is expanding the use of digital dentistry technologies for producing highly customized oral sleep apnea devices. Clinics across South Korea increasingly leverage CAD/CAM workflows to improve appliance fit, production efficiency, and patient comfort.
United States 🇺🇸
Customized Therapy SolutionsThe U.S. oral sleep apnea devices market is driven by demand for customized mandibular advancement devices that provide comfortable alternatives to conventional therapies. Dental sleep medicine providers in the U.S. continue expanding digital workflows and patient-specific appliance manufacturing.
Segment Leadership and Growth Trends
Oral Sleep Apnea Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Mandibular Advancement Devices (Largest Segment) vs Tongue Retaining Devices (Fastest-Growing Segment)
Mandibular advancement devices held the largest share of the oral sleep apnea devices market in 2026, supported by their established use in managing obstructive sleep apnea by repositioning the lower jaw to help maintain airway openness during sleep. Their non-invasive nature and suitability for patients seeking alternatives to more intensive treatment approaches contribute to their widespread adoption. Growing awareness of sleep-related breathing disorders and increasing preference for oral treatment options are sustaining demand for mandibular advancement devices.
Tongue retaining devices are the fastest-growing product segment, driven by growing interest in oral appliances that address airway obstruction through an alternative mechanism. These devices can help maintain airway patency by positioning the tongue forward during sleep, offering another non-invasive approach for patients with sleep-disordered breathing. Increasing awareness of oral appliance therapy and demand for convenient treatment options are supporting broader consideration of tongue retaining devices.
Sales Channel Segment Analysis: Direct Sales (Largest Segment) vs Online Sales (Fastest-Growing Segment)
Direct sales represented the largest share of the oral sleep apnea devices market in 2026, reflecting the importance of personalized product selection, professional guidance, and direct interaction in the purchase of oral sleep apnea devices. These products often require consideration of patient-specific treatment needs and device suitability, making direct channels valuable for facilitating informed purchasing decisions. Established relationships between healthcare providers, suppliers, and patients continue to support the prominence of direct sales.
Online sales are the fastest-growing sales channel, supported by increasing consumer comfort with purchasing healthcare products through digital platforms. Online channels provide convenient access to product information, comparisons, and purchasing options, particularly for consumers seeking greater flexibility in acquiring oral sleep apnea devices. Expanding digital commerce and rising consumer interest in convenient healthcare purchasing are creating stronger opportunities for online distribution.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Mandibular Advancement Devices, Tongue Retaining Devices, Others | Mandibular Advancement Devices | Tongue Retaining Devices |
| Sales Channel | Direct Sales, Distributors, Online Sales | Direct Sales | Online Sales |
| End-use | Hospitals, Homecare Settings, Sleep Clinics, Others | Homecare Settings | Homecare Settings |
Competitive Landscape and Market Positioning
Major players in the oral sleep apnea devices market:
1. ResMed Inc. (United States)
2. SomnoMed Limited (Australia)
3. ProSomnus Sleep Technologies Inc. (United States)
4. Vivos Therapeutics Inc. (United States)
5. Koninklijke Philips N.V. (Netherlands)
6. Oventus Medical Ltd. (Australia)
7. Airway Management Inc. (United States)
8. Whole You Inc. (United States)
9. Apnea Sciences Corporation (United States)
10. DynaFlex (United States)
The oral sleep apnea devices market is evolving through increased demand for comfortable and non-invasive treatment solutions designed to improve patient compliance and long-term therapy outcomes. Manufacturers are focusing on ergonomic device customization, digital fitting technologies, and improved airway support mechanisms to enhance treatment effectiveness. Rising awareness regarding sleep disorders and preventive healthcare is also supporting growth within the oral sleep apnea devices market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| ResMed Inc. (United States) | |||||||
| SomnoMed Limited (Australia) | |||||||
| ProSomnus Sleep Technologies Inc. (United States) | |||||||
| Vivos Therapeutics Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Oventus Medical Ltd. (Australia) | |||||||
| Airway Management Inc. (United States) | |||||||
| Whole You Inc. (United States) | |||||||
| Apnea Sciences Corporation (United States) | |||||||
| DynaFlex (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| ResMed | May-25 | ResMed acquired VirtuOx, a specialized independent diagnostic testing facility, to integrate home-based diagnostic services into its digital sleep-health ecosystem. This strategic move aims to streamline the patient care pathway by reducing bottlenecks between initial evaluation and the initiation of obstructive sleep apnea therapy. |
| Sleep Number | Mar-25 | Sleep Number integrated its BreatheIQ app with the GEM SLEEP virtual care clinic. This partnership provides 53 million health-plan members with a streamlined digital pathway to connect with specialized clinicians for OSA diagnosis and treatment planning, bypassing traditional barriers to care. |
| Vivos Therapeutics | Oct-24 | Vivos Therapeutics secured new CPT codes from the American Medical Association for its CARE oral medical devices. This regulatory milestone facilitates standardized insurance coverage and reimbursement for its airway remodeling technology, significantly improving market access for patients with obstructive sleep apnea. |
| Apnimed | Sep-24 | Apnimed and Shionogi expanded their collaborative efforts within the Shionogi-Apnimed Sleep Science (SASS) joint venture. This partnership focuses on the development of novel pharmacological therapies as non-invasive alternatives to oral devices and CPAP, directly addressing the underlying neurobiological causes of upper airway collapse in OSA patients. |
| EnsoData | Feb-24 | EnsoData received FDA clearance for its AI-powered diagnostic software that utilizes data from pulse oximeters to identify sleep-related breathing disorders. This technology enhances the scalability of at-home sleep apnea testing, providing a critical digital tool for rapid patient screening and diagnostic triage in sleep medicine. |
| Vivos Therapeutics | Nov-23 | Vivos Therapeutics received FDA clearance for its CARE (complete airway repositioning and expansion) oral appliances for the treatment of obstructive sleep apnea. This regulatory approval provided the company with a significant expansion of its clinical product portfolio, enabling it to target a broader range of OSA patient demographics. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Oral Sleep Apnea Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Severity Level | Mild Obstructive Sleep Apnea, Moderate Obstructive Sleep Apnea, Severe Obstructive Sleep Apnea |
| Reimbursement Coverage | Fully Reimbursed, Partially Reimbursed, Self-Pay |
| Patient Age Group | Adults, Older Adults |
Oral Sleep Apnea Devices Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Patient Journey and Treatment Adoption Assessment |
|
| Sleep Clinic Referral Network Analysis |
|
| Home-Based Sleep Care Ecosystem Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the oral sleep apnea devices market?
What is the expected industry size of oral sleep apnea devices by 2036?
Why are mandibular advancement devices gaining wider adoption in the oral sleep apnea devices market?
How is telehealth expanding opportunities in the oral sleep apnea devices market?
What makes Mandibular Advancement Devices the leading product segment in the oral sleep apnea devices market?
Which sales channel is growing fastest in the oral sleep apnea devices market?
Why is North America the largest market for oral sleep apnea devices?
How is Asia Pacific creating growth opportunities in oral sleep apnea devices?
Who are the major participants shaping the oral sleep apnea devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization